Oxford BioMedica (GB:OXB) has released an update.
Oxford BioMedica PLC has announced a significant change in shareholder voting rights, with investment giant BlackRock, Inc. adjusting its stake. On October 1, 2024, BlackRock’s total voting rights crossed the threshold to reach 5.23%, an increase from a previous 5.01%, comprising both direct and financial instrument-related voting rights. This notification of major holdings indicates a noteworthy shift in the company’s investment profile that could influence investor decisions.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
